Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sabra Health Care REIT (SBRA)

Sabra swings to Q2 net loss of $0.10 a share; revenue rises to $235.9 million

Mixed Impact 3 of 5 earnings Written later

Sabra Health Care REIT reported a second-quarter 2026 net loss of $0.10 per diluted share, compared with net income of $0.27 per diluted share a year earlier, after a $102.4 million provision for loan losses and other reserves. Total revenues rose to $235.9 million from $189.2 million, and normalized FFO per diluted share was $0.38 versus $0.37, while the company reiterated its full-year 2026 guidance.

Key points

  • Q2 2026 net loss of $0.10 per diluted share vs. net income of $0.27 in Q2 2025
  • Total revenues of $235.9 million vs. $189.2 million in Q2 2025; provision for loan losses and other reserves of $102.4 million
  • Normalized FFO of $0.38 per diluted share vs. $0.37; normalized AFFO of $0.40 vs. $0.38
  • Full-year 2026 guidance reiterated; quarterly dividend of $0.30 per share payable August 31, 2026

The filing

CompanySabra Health Care REIT (SBRA)
Form8-K, current report
Filed with the SECAug 3, 2026, 4:05 PM ET
Accession number0001492298-26-000027

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.